Petra Mazzocchetti

University of Perugia — Italy

Neuroscience · Life Sciences

13h-index1.0kcitations18works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroscience and Neuropharmacology Research(11), Parkinson's Disease Mechanisms and Treatments(6), Epilepsy research and treatment(5), Alzheimer's disease research and treatments(4), Neurological disorders and treatments(4)

Publications18 total

Locally Synthetized 17-β-Estradiol Reverses Amyloid-β-42-Induced Hippocampal Long-Term Potentiation Deficits
International Journal of Molecular Sciences·2024· 4 citedOpen Access
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis
Cell Reports·2021· 81 citedOpen Access
Interleukin-17 axis in the modulation of cortical and subcortical synaptic plasticity across disease stages in experimental multiple sclerosis
Journal of the Neurological Sciences·2021
From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2
Frontiers in Cellular Neuroscience·2020· 20 citedOpen Access
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition
Neurobiology of Disease·2020· 20 citedOpen Access
Effects of safinamide on the glutamatergic striatal network in experimental Parkinson’s disease
Neuropharmacology·2020· 14 cited
Differential effect of FHM2 mutation on synaptic plasticity in distinct hippocampal regions
Cephalalgia·2019· 12 cited
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration
Brain·2019· 115 citedOpen Access
Striatal spreading depolarization: Possible implication in levodopa‐induced dyskinetic‐like behavior
Movement Disorders·2019· 11 citedOpen Access
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences
Current Neuropharmacology·2018· 355 citedOpen Access
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease
Neurobiology of Disease·2018· 28 citedOpen Access
Lacosamide protects striatal and hippocampal neurons from in vitro ischemia without altering physiological synaptic plasticity
Neuropharmacology·2018· 13 cited
Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson’s disease
Cell Death and Disease·2018· 56 citedOpen Access
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis
Neurobiology of Disease·2018· 36 citedOpen Access
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link?
Neurobiology of Aging·2016· 90 cited
Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs
Neurochemical Research·2015· 17 cited
Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system
Frontiers in Cellular Neuroscience·2015· 48 citedOpen Access
Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?
Philosophical Transactions of the Royal Society B Biological Sciences·2015· 112 citedOpen Access

Frequent Co-authors

Paolo Calabresi(17), Alessandro Tozzi(15), Cinzia Costa(13), Massimiliano Di Filippo(11), Andrea Mancini(8), Valentina Durante(7), Michela Tantucci(7), Miriam Sciaccaluga(7), Alfredo Megaro(6), Antonio de Iure(5), Barbara Picconi(5), Laura Bellingacci(5), Veronica Ghiglieri(4), Guendalina Bastioli(4), Ana Quiroga‐Varela(3), Davide Chiasserini(3), Lucilla Parnetti(3), Lorenzo Gaetani(3), Michele Romoli(2), Sabrina Siliquini(2)